JP drafts for public comments (September 30, 2024)
JP drafts for public comments (September 2, 2024) No.1
JP drafts for public comments (September 2, 2024) No.2
JP drafts for public comments (June 2024) No.1
JP drafts for public comments (June 2024) No.2
JP drafts for public comments (March 2024)
JP drafts for public comments (December 2023)
JP drafts for public comments (September 2023)
Menu
Close
Back
-
- Outline of Regulatory Science
- Regulatory Science
- Regulatory Science Research Administration
- Regulatory Science Coordination
- Standard Development
- The Science Board
- Measures for advanced science and technology
- RS Projects Across Multi-Offices in PMDA
- Outline
- Japanese Pharmacopoeia
- Medical Device Standards
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety Measures
- Home
- Regulatory Science/The Science Board/Standard Development
- Standard Development
- Japanese Pharmacopoeia
- JP Drafts
- New draft monographs and general tests for the JP 19th edition
Regulatory Science/The Science Board/Standard Development